Literature DB >> 33646168

Neuropsychiatric Symptoms in Patients with Dementia Associated with Increased Psychological Distress in Caregivers During the COVID-19 Pandemic.

Wyllians Vendramini Borelli1, Marina Coutinho Augustin1, Paola Bell Felix de Oliveira1, Lorenzo Casagrande Reggiani2, Renato Gorga Bandeira-de-Mello3, Artur Francisco Schumacher-Schuh1,4, Marcia Lorena Fagundes Chaves1, Raphael Machado Castilhos1.   

Abstract

BACKGROUND: The social isolation imposed by COVID-19 pandemic can have a major impact on the mental health of dementia patients and their caregivers.
OBJECTIVE: We aim to evaluate the neurological decline of patients with dementia and the caregivers' burden during the pandemic.
METHODS: We performed a cross-sectional study. Caregivers of dementia patients following in the outpatient clinic were included. A structured telephone interview composed of the Neuropsychiatric Inventory Questionnaire (NPI-Q), Zarit Burden Interview (ZBI), Beck Depression (BDI) and Anxiety (BAI) Inventories to address cognitive, behavioral, and functional changes associated with social distancing during the Sars-Cov-2 outbreak. Patients were divided in two groups according to caregivers' report: with perceived Altered Cognition (AC) and Stable Cognition (SC).
RESULTS: A total of 58 patients (median age: 57 years [21-87], 58.6%females) and caregivers (median age: 76.5 years [55-89], 79.3%females) were included. Cognitive decline was shown by most patients (53.4%), as well as behavioral symptoms (48.3%), especially apathy/depression (24.1%), and functional decline (34.5%). The AC group (n = 31) presented increased behavioral (67.7%versus 25.9%, p = 0.002) and functional (61.3%versus 3.7%, p < 0.001) changes when compared to the SC group. In the AC group, ZBI, BDI, NPI-Q caregiver distress, and NPI-Q patient's severity of symptoms scores were worse than the SC group (p < 0.005 for all).
CONCLUSION: Patients' neuropsychiatric worsening and caregiver burden were frequent during the pandemic. Worsening of cognition was associated with increased caregivers' psychological distress.

Entities:  

Keywords:  Alzheimer’s disease; COVID-19; Sars-Cov-2; dementia; mental health; social isolation

Mesh:

Year:  2021        PMID: 33646168     DOI: 10.3233/JAD-201513

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

1.  The Effect of a Tele-Health Intervention Program on Home-Dwelling Persons with Dementia or MCI and on Their Primary Caregivers during the Stay-at-Home-Order Period in the COVID-19 Pandemic Outbreak: Evidence from Taiwan.

Authors:  Yi-Ling Lai; Wen-Yi Chen; Lin-Ying Hsu; Chin-Hua Fu
Journal:  Healthcare (Basel)       Date:  2022-05-24

2.  The effect of COVID-19 isolation measures on the cognition and mental health of people living with dementia: A rapid systematic review of one year of quantitative evidence.

Authors:  Aida Suárez-González; Jayeeta Rajagopalan; Gill Livingston; Suvarna Alladi
Journal:  EClinicalMedicine       Date:  2021-07-31

3.  The Mental Health of Caregivers and Their Patients With Dementia During the COVID-19 Pandemic: A Systematic Review.

Authors:  Elvira Anna Carbone; Renato de Filippis; Roberta Roberti; Marianna Rania; Laura Destefano; Emilio Russo; Giovambattista De Sarro; Cristina Segura-Garcia; Pasquale De Fazio
Journal:  Front Psychol       Date:  2021-12-24

4.  Caregivers of people with dementia and mental health during COVID-19: findings from a cross-sectional study.

Authors:  Anna Messina; Martina Lattanzi; Emiliano Albanese; Maddalena Fiordelli
Journal:  BMC Geriatr       Date:  2022-01-16       Impact factor: 3.921

5.  The Neuropsychiatric Changes After COVID-19 Quarantine in Patients With Cognitive Impairment and Their Caregivers in Chongqing, China: A Cohort Study.

Authors:  Shiyun Yuan; Wenbo Zhang; Qiang Yao; Wenqi Lü; Wuhan Yu; Fuxin Zhong; Yan Wang; Dianxia Xing; Xiaoqin Wang; Jiaqi Song; Hong Huang; Chenxi Chen; Junjin Liu; Weihua Yu; Yang Lü
Journal:  Front Aging Neurosci       Date:  2022-02-10       Impact factor: 5.750

6.  Minimal Impact of COVID-19 Pandemic on the Mental Health and Wellbeing of People Living With Dementia: Analysis of Matched Longitudinal Data From the IDEAL Study.

Authors:  Serena Sabatini; Holly Q Bennett; Anthony Martyr; Rachel Collins; Laura D Gamble; Fiona E Matthews; Claire Pentecost; Eleanor Dawson; Anna Hunt; Sophie Parker; Louise Allan; Alistair Burns; Rachael Litherland; Catherine Quinn; Linda Clare
Journal:  Front Psychiatry       Date:  2022-03-09       Impact factor: 4.157

7.  Impact of COVID-19 on carers of people with dementia in the community: Findings from the British IDEAL cohort.

Authors:  Catherine Quinn; Laura D Gamble; Sophie Parker; Anthony Martyr; Rachel Collins; Christina Victor; Eleanor Dawson; Anna Hunt; Claire Pentecost; Louise Allan; Linda Clare
Journal:  Int J Geriatr Psychiatry       Date:  2022-03-24       Impact factor: 3.850

Review 8.  The Effects of COVID-19 lockdown on neuropsychiatric symptoms in patients with dementia or mild cognitive impairment: A systematic review and meta-analysis.

Authors:  Pinar Soysal; Lee Smith; Mike Trott; Panagiotis Alexopoulos; Mario Barbagallo; Semen Gokce Tan; Ai Koyanagi; Susan Shenkin; Nicola Veronese
Journal:  Psychogeriatrics       Date:  2022-02-06       Impact factor: 2.295

9.  Association Between Dementia Development and COVID-19 among Individuals Who Tested Negative for COVID-19 in South Korea: A Nationwide Cohort Study.

Authors:  Namwoo Kim; Sungtaek Son; Saemina Kim; Jieun Lee; Yong Min Ahn; Dong Keon Yon; Bong-Jin Hahm
Journal:  Am J Alzheimers Dis Other Demen       Date:  2022 Jan-Dec       Impact factor: 2.035

10.  A Single-Case Design Investigation for Measuring the Efficacy of Gestalt Therapy to Treat Depression in Older Adults with Dementia in Italy and in Mexico: A Research Protocol.

Authors:  Alessandra Merizzi; Rosanna Biasi; José Fernando Álvarez Zamudio; Margherita Spagnuolo Lobb; Mirko Di Rosa; Sara Santini
Journal:  Int J Environ Res Public Health       Date:  2022-03-10       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.